Growth Metrics

Ardelyx (ARDX) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.32%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -10.19%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 24.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.92%
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn 20.24%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.24%
Dec 31, 2025 46.09%
Sep 30, 2025 101.26%
Jun 30, 2025 110.93%
Mar 31, 2025 63.40%
Dec 31, 2024 48.17%
Sep 30, 2024 -7.89%
Jun 30, 2024 -4.51%
Mar 31, 2024 -7.53%
Dec 31, 2023 -17.50%
Sep 30, 2023 -13.76%
Jun 30, 2023 -30.95%
Mar 31, 2023 -46.11%
Dec 31, 2022 -48.22%
Sep 30, 2022 -51.19%
Jun 30, 2022 -42.20%
Mar 31, 2022 -10.78%
Dec 31, 2021 22.00%
Sep 30, 2021 25.58%
Jun 30, 2021 6.60%
Mar 31, 2021 -22.78%
Dec 31, 2020 -43.66%
Sep 30, 2020 -46.46%
Jun 30, 2020 -44.04%
Mar 31, 2020 -41.83%
Dec 31, 2019 -38.76%
Sep 30, 2019 -34.24%
Jun 30, 2019 -33.19%
Mar 31, 2019 -30.66%
Dec 31, 2018 -30.14%
Sep 30, 2018 -30.46%
Jun 30, 2018 -28.34%
Mar 31, 2018 -17.46%
Dec 31, 2017 -10.67%
Sep 30, 2017 23.72%
Jun 30, 2017 93.39%
Mar 31, 2017 93.93%
Dec 31, 2016 90.85%
Sep 30, 2016 58.71%
Jun 30, 2016 18.86%
Mar 31, 2016 39.77%
Dec 31, 2015 121.07%
Sep 30, 2015 281.16%
Jun 30, 2015 256.85%
Dec 31, 2014 302.08%